Literature DB >> 1011991

Coagulant protein of Russell's viper venom.

B C Furie, B Furie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1011991     DOI： 10.1016/s0076-6879(76)45019-x

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  9 in total

1.  Restricted active site docking by enzyme-bound substrate enforces the ordered cleavage of prothrombin by prothrombinase.

Authors:  Ayse Hacisalihoglu; Peter Panizzi; Paul E Bock; Rodney M Camire; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2007-09-11       Impact factor: 5.157

2.  Comparative study of anticoagulant and procoagulant properties of 28 snake venoms from families Elapidae, Viperidae, and purified Russell's viper venom-factor X activator (RVV-X).

Authors:  Montamas Suntravat; Issarang Nuchprayoon; John C Pérez
Journal:  Toxicon       Date:  2010-09-15       Impact factor: 3.033

3.  Factor X M402T: a homozygous missense mutation identified as the cause of cross-reacting material-reduced deficiency.

Authors:  Yushi Chikasawa; Keiko Shinozawa; Kagehiro Amano; Kyoichi Ogata; Takeshi Hagiwara; Takashi Suzuki; Hiroshi Inaba; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2014-07-27       Impact factor: 2.490

4.  Phylogenetic analysis of serine proteases from Russell's viper (Daboia russelli siamensis) and Agkistrodon piscivorus leucostoma venom.

Authors:  Pattadon Sukkapan; Ying Jia; Issarang Nuchprayoon; John C Pérez
Journal:  Toxicon       Date:  2011-05-27       Impact factor: 3.033

5.  Converting blood coagulation factor IXa into factor Xa: dramatic increase in amidolytic activity identifies important active site determinants.

Authors:  K P Hopfner; H Brandstetter; A Karcher; E Kopetzki; R Huber; R A Engh; W Bode
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

6.  Characterization of the defect in activation of factor IX Chapel Hill by human factor XIa.

Authors:  K M Braunstein; C M Noyes; M J Griffith; R L Lundblad; H R Roberts
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

7.  The missense Thr211Pro mutation in the factor X activation peptide of a bleeding patient causes molecular defect in the clotting cascade.

Authors:  Qiulan Ding; Yiping Shen; Likui Yang; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2013-05-16       Impact factor: 5.249

8.  Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom.

Authors:  Ren-Chieh Wu; Ping-Tse Chou; Li-Kuang Chen
Journal:  Thromb J       Date:  2016-10-04

9.  Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs.

Authors:  Raul Altman; Claudio Daniel Gonzalez
Journal:  Thromb J       Date:  2014-03-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.